Natural History of Wilson Disease

NCT03334292 · tracked via the Priya Life Science Germany tracker

Sponsor

Yale University

Phase

Observational

Started

2017-12-18

Last updated

2026-06-22

Condition(s) studied

Wilson Disease

Study summary

The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Known diagnosis of WD * Able and willing to provide informed consent for adults (Parental/guardian permission (informed consent) and if appropriate, child assent for participants \<18 (or per local Institutional Review Board (IRB) regulation) Exclusion Criteria: * Diagnosis of WD has been excluded * Unwilling to provide informed consent or assent

Primary outcome measure(s)

Create registry for Wilson disease — 5 Years
This outcome is a binary 'yes/no' outcome as to whether or not this study can successfully create a repository with the intent to store data and specimens to support the conduct of future research on Wilson disease.

Trial sites (6)

Facility	City	Region	Status
Yale University	New Haven	Connecticut	Recruiting
Advent Health	Orlando	Florida	Recruiting
Baylor College of Medicine	Houston	Texas	Recruiting
Seattle Children's Hospital	Seattle	Washington	Active Not Recruiting
Universitätsklinikum Heidelberg	Heidelberg	Germany	Recruiting
Royal Surrey Country Hospital	Guildford	Surrey	Active Not Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03334292 on ClinicalTrials.gov ↗ ← All trials in Germany